Apply an intervention protocol to support cessation in smokers During hospitalization and at discharge. Includes assessment of the degree of satisfaction With the intervention.
A prospective descriptive study of 10 male smokers who were admitted during April 2014 on a total of 50 male patients (20%) was performed. The protocol consisted of delivering a prospectus, a medical interview (general and smoking history) and mislead contraindications and / or refusal of treatment. Daily monitoring was performed with response evaluation and possible complications. Satisfaction was evaluated and treatment regimen was controlled 10 or 15 days according to pathology. At follow persistent cessation or relapse were evaluated and georeferenced to a smoking cessation program.
Nine patients was included, but one patient remained abstinent anyway and one of the included, despite smoking ban since 2006, kept smoking indoors, although to a lesser fullest extent (25%) . Behavioral intervention was used together Bupropion 150 mg twice a day except one that provided a contraindication (epilepsy). No side effects occurred at all . In 5 of them included in the study who had insomnia and / or anxiety, benzodiazepines (clonazepam ) were added. Only one of them smoked at discharge. Two of them who didn´t smoke at discharge, latter smoked in ambulatory control, although less than before admission. No correlation between oncology and pathology even cessation was found. All patients included in the study were satisfied at discharge and post discharge, independent monitoring of the degree of abstinence.
Despite Uruguay ratified FCTC ten years ago, there is still a high percentage of smokers admitted to hospitals. This pilot experience in patients with high motivation (high percentage of surgical patients) improved assistance and constitutes a public health measure itself. Apply all measures at our disposal for the cessation of smoking at every opportunity is our ethical and professional obligation.